Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-28 Hoge Stephen President Exercise or conversion 10b5-1 +2,411 1,515,844
2024-02-28 Hoge Stephen President Exercise or conversion 10b5-1 +2,442 1,518,286
2024-02-28 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −2,411 0
2024-02-28 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −2,442 7,326
2024-02-27 Mock James M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +23,635 23,635
2024-02-27 Mock James M Chief Financial Officer Grant or award · Restricted Stock Units +12,377 12,377
2024-02-27 Mock James M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,216 60,216
2024-02-27 Mock James M Chief Financial Officer Grant or award · Restricted Stock Units +5,304 5,304
2024-02-27 Klinger Shannon Thyme Chief Legal Officer Grant or award · Stock Option (Right to Buy) +23,635 23,635
2024-02-27 Klinger Shannon Thyme Chief Legal Officer Grant or award · Restricted Stock Units +12,377 12,377
2024-02-27 Klinger Shannon Thyme Chief Legal Officer Grant or award · Stock Option (Right to Buy) +60,216 60,216
2024-02-27 Klinger Shannon Thyme Chief Legal Officer Grant or award · Restricted Stock Units +10,609 10,609
2024-02-27 Hoge Stephen President Grant or award · Stock Option (Right to Buy) +43,894 43,894
2024-02-27 Hoge Stephen President Grant or award · Restricted Stock Units +22,987 22,987
2024-02-27 Bancel Stephane Chief Executive Officer Grant or award · Stock Option (Right to Buy) +151,943 151,943
2024-02-22 Hoge Stephen President Sale 10b5-1 −15,000 $100.00 $1.5M 1,513,433
2024-02-16 Hoge Stephen President Sale 10b5-1 −10,542 $88.88 $937K 1,528,433
2024-02-16 Bancel Stephane Chief Executive Officer Sale 10b5-1 −26,351 $88.88 $2.3M 5,460,224
2024-02-14 Hoge Stephen President Grant or award 10b5-1 +22,694 1,538,975
2024-02-14 Bancel Stephane Chief Executive Officer Grant or award 10b5-1 +56,736 5,486,575

Page 35 of 38 · 743 trades